Retatrutide is a newly developed drug that acts as a powerful GLP-1 receptor stimulator. This innovative treatment holds significant promise for managing type 2 diabetes. By imitating the actions of natural GLP-1, Retatrutide enhances insulin secretion and reduces glucagon release, leading to improved glucose control. Clinical trials have demonstra